Meridian Bioscience, Inc. announced that John C. McIlwraith has been elected as Chairman of the Meridian Board of Directors, effective January 26, 2022. Mr. McIlwraith succeeds David C. Phillips, who retired after serving for more than 21 years on the Meridian Bioscience Board. Mr. McIlwraith is a Managing Director of Allos Ventures, a venture capital firm, where he leads investments in early-stage technology companies.

Prior to co-founding Allos Ventures in 2010, Mr. McIlwraith was a Managing Director of Blue Chip Venture Company. He has served on the board of directors of more than 20 healthcare or information technology companies, including as the Chairman of the Board and later Lead Director of Assurex Health, the provider of a pharmacogenetic test that analyzed genetic variations which impact how patients metabolize and respond to medications that treat mental health conditions. Mr. McIlwraith has served on the Meridian Bioscience Board since 2015.